Moreover, restriction of the risk conferred by FGFR2 variants to ER-positive and PR-positive tumors suggests that these SNPs affect the reproductive hormone-related pathway in the development of breast cancer in North Indian women. The gene discussed is FGFR2; the disease is breast carcinoma.